Through this subsidiary, the company will analyze patient DNA from saliva samples and do genomic research to predict the efficiency of use Medical Cannabis for treatment of various conditions.
The company has executed an agreements with world renowned Bioinformatics & Genomics centers for use of their genomics labs, analytical systems and bio-informatics super computers.
Our research is creating medicine which will benefit the patient without destroying their organs and without the side effects that are so harmful to the patient. We believe that the systematic failure to consider problems with the endocannabinoid system in the treatment of patients has led to a pharmaceutical epidemic. The side effects which result from this failure are often worse than the symptoms originally being treated. MMJ Genomics is leading the development of precision medicine and human genomics research. We will empower our patients through research and knowledge. We intend to remove the stigma attached to medical marijuana and broaden the treating base of patients of several chronic diseases who are unaware of the medicinal value. This is the core value that motivates our MMJ Team.